Background

Filip joined Burnet Institute in 2019 on the Disease Elimination and Behaviours and Health Risks programs. He will be conducting research on Eliminating Hepatitis C cohort study as well as policy related to take-home naloxone in Australia.

Qualifications

• Masters of Public Health, University of Melbourne 2018
• BA (Honours), Swinburne 2013
• Bachelor of Social Science, Swinburne 2012

Projects (2)

Current (2)

• 

  Feasibility study for a potential medically supervised injecting centre/drug consumption service for the ACT

• 

  IDRS: Illicit Drug Reporting System

Publications (8)

2022 (3)

• Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a 'moral hazard' associated with naloxone supply.
  Tse WC, Djordjevic F, Borja V, Picco L, Lam T, Olsen A, Larney S, Dietze P, Nielsen S
  Int J Drug Policy. 2022 Feb; 100:103513
• The feasibility of a drug consumption room in the Australian Capital Territory.
  Kirwan A, Winter R, Gunn J, Djordjevic F, Curtis M, Gough C, Dietze PM
  Drug Alcohol Rev. 2022 Jan; Epub ahead of print
• Exploring hepatitis C virus testing and treatment engagement over time in Melbourne, Australia: a study protocol for a longitudinal cohort study (EC-Experience Cohort study).
  O'Keefe D, Gunn J, Ryan K, Djordjevic F, Kerr P, Gold J, Elsum I, Layton C, Chan K, Dietze P, Higgs P, Doyle J, Stoové MA, Hellard M, Pedrana AE
  BMJ Open. 2022 Jan; 12(1):e057618

2021 (4)

• Health service utilisation and experiences of stigma among people who inject drugs in Melbourne, Australia.
  Djordjevic F, Ryan K, Gunn J, Brener L, O'Keefe D, Draper B, Schroeder S, Gold J, Treloar C, Broady T, Dietze P, Hellard M, Pedrana A
  J Viral Hepat. 2021 Sep; 28(12):1738-1743
• Ketamine Use Among People Who Regularly Use Ecstasy and Other Illicit Stimulants in Australia: Trends and Characteristics of Use, 2009-2019.
  Stewart AC, Peacock A, Djordjevic F, Cossar R, Salom C, Lenton S, Dietze P
  J Stud Alcohol Drugs. 2021 Mar; 82(2):188-196
• The impact of Victoria's real time prescription monitoring system (SafeScript) in a cohort of people who inject drugs.
  Fetene DM, Higgs P, Nielsen S, Djordjevic F, Dietze P
  Med J Aust. 2021 Mar; 214(5):234-234.e1
• Increasing hepatitis C testing and linkage to care: Results of a testing campaign with incentives at primary care clinics in Melbourne, Australia.
  Chan K, Elsum I, Gold J, Layton C, Accadia L, Bryant M, Gunn J, Djordjevic F, Purcell I, Dicka J, Forrest M, Crawford S, Hellard M, Pedrana A; Eliminate Hepatitis C Partnership
  J Viral Hepat. 2021 Jan; 28(3):569-572

2020 (1)

• The impact of Victoria's real time prescription monitoring system (SafeScript) on a cohort of people who inject drugs.
  Fetene DM, Higgs P, Nielsen S, Djordjevic F, Dietze P
  Med J Aust. 2020 Aug; 213(3):141-141.e1

News Articles (1)

2020 (1)

• Focus on follow-up care to real-time prescription monitoring